Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential
Clear cell renal cell carcinoma (ccRCC) poses a significant global health challenge as its incidence continues to rise, resulting in a substantial annual mortality rate. Major clinical challenges to current ccRCC treatments include high drug-resistance rates as well as dose-limiting adverse events;...
Saved in:
Main Authors: | Aseel O. Rataan, Yan Xu, Sean M. Geary, Yousef Zakharia, Eman S. Kamel, Youcef M. Rustum, Aliasger K. Salem |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Cancer Treatment and Research Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294225000024 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ClearFinder: a Python GUI for annotating cells in cleared mouse brain
by: Stefan Pastore, et al.
Published: (2025-01-01) -
Cytomegalovirus Infection in Patient with Clear Cell Renal Cell Carcinoma
by: Ikhwan Rinaldi, et al.
Published: (2023-01-01) -
Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma
by: Dinh-Xuan Pham, et al.
Published: (2025-02-01) -
Clear Cell Carcinoma Arising in Vulvar Endometriosis
by: Pranom Buppasiri, et al.
Published: (2018-01-01) -
Renal Clear Cell Carcinoma and Tonsil Metastasis
by: Dario Marcotullio, et al.
Published: (2013-01-01)